Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1662774 · IRLA

IRulya Therapeutics Inc.

Filing with the SEC SEC-reporting company New Haven, CT Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Sep 4, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Several leadership changes6 reports of director or officer changes (Item 5.02) in the last 180 days.
  • Stockholders’ deficitAt the end of 2025 total liabilities exceeded total assets: stockholders’ equity was −$35.7M (XBRL data filed with the SEC).
  • Net loss in 2025Net loss of $84M for the year (2024: −$56.8M).
  • Private capital raiseOn Jun 11, 2026 the company filed Form D. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$84M−$56.8M
Total assets$93.5M$114M
Total liabilities$129M$84.3M
Stockholders’ equity−$35.7M$30.1M
Cash and equivalents$5.8M$6.2M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
IRulya Therapeutics Inc.
Formerly: Quince Therapeutics, Inc.
CIK
0001662774
Tickers
IRLA
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
New Haven, Connecticut
Industry (SIC)
2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 13, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 13, 2026 · filing · edition of Nov 13, 2026
  • Directors or officers changed
    Form 8-K · items 5.02, 5.03, 7.01, 8.01, 9.01 · filed Oct 9, 2026 · filing
  • Director or officer change: Director or officer change
    Form 8-K · items 5.02, 5.03, 5.07, 9.01 · filed Oct 6, 2026 · filing
  • Director or officer change: Director change
    Form 8-K · items 5.02 · filed Oct 2, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 2.01, 5.02, 9.01 · filed Sep 14, 2026 · filing
  • Acquisition or disposal completed
    Form 8-K · items 2.01, 5.02, 9.01 · filed Sep 14, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Sep 4, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Aug 27, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 14, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jul 31, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jun 11, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jun 11, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 3.02, 5.02, 5.03, 7.01, 9.01 · filed May 18, 2026 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 3.02, 5.02, 5.03, 7.01, 9.01 · filed May 18, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 11, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Apr 22, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Apr 10, 2026 · filing
  • Late annual report notice: Annual report (10-K) will be late
    Form NT 10-K · filed Apr 1, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Mar 20, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 8.01 · filed Feb 12, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Feb 2, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 12, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 11, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 11, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jul 1, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 13, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 24, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 24, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 13, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 13, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Nov 13, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 13, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 13, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jun 21, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 13, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Apr 1, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Feb 15, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jan 29, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Dec 8, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 14, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Oct 26, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 2.03, 5.02, 9.01 · filed Oct 23, 2023 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 2.03, 5.02, 9.01 · filed Oct 23, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.03, 5.02 · filed Sep 6, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Aug 10, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 3, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.02, 2.03, 3.02, 5.02, 7.01, 8.01, 9.01 · filed Jul 24, 2023 · filing
  • Results announced
    Form 8-K · items 1.01, 2.02, 2.03, 3.02, 5.02, 7.01, 8.01, 9.01 · filed Jul 24, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 15, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Mar 28, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 15, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Mar 3, 2023 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.02, 2.05, 8.01 · filed Jan 30, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 2.05, 8.01 · filed Jan 30, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 5.02 · filed Jan 27, 2023 · filing